pyrimidin-2-one beta-ribofuranoside and Granulocytic Leukemia

pyrimidin-2-one beta-ribofuranoside has been researched along with Granulocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DeCoteau, JF; Geyer, CR; Lakshimikuttysamma, A; Sanche, SE; Scott, SA; Sheridan, DP	1

Other Studies

1 other study(ies) available for pyrimidin-2-one beta-ribofuranoside and Granulocytic Leukemia

Article	Year
Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. Experimental hematology, 2007, Volume: 35, Issue:2 Topics: Acetylation; Acute Disease; Apoptosis; Cell Division; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p15; Cytidine; DNA Methylation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; G2 Phase; Gene Expression Profiling; Histones; HL-60 Cells; Humans; Hydroxamic Acids; Leukemia, Myeloid; Phosphorylation; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction	2007

Article

Year

Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.

Experimental hematology, 2007, Volume: 35, Issue:2

Topics: Acetylation; Acute Disease; Apoptosis; Cell Division; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p15; Cytidine; DNA Methylation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; G2 Phase; Gene Expression Profiling; Histones; HL-60 Cells; Humans; Hydroxamic Acids; Leukemia, Myeloid; Phosphorylation; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction

2007